European Countries To Resume Using AstraZeneca COVID-19 Vaccine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

Weeks ago, there were reports that the AstraZeneca COVID-19 vaccine was causing blood clots. This caused many European countries to stop administering the vaccine when though WHO has suggested that there was no trace of the blood clots to the vaccine.

Germany, France, Italy, and Spain, have resumed the use of Oxford’s AstraZeneca vaccine. The European Medicines Agency looked at 25 cases of unusual blood clots in about 20 million people who had acquired AstraZeneca vaccines. It is unknown whether the vaccine caused the blood clots, but health authorities believe the benefits outweigh the consequences.

Meanwhile, the Biden administration said it plans to ship about 4 million doses of U.S.-made AstraZeneca vaccine to Mexico and Canada.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp

Get Breaking News Directly In Your Inbox

YOU MIGHT ALSO LIKE...